SUBSEQUENT EVENTS (Narrative) (Details) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
May 28, 2026 |
May 27, 2026 |
May 15, 2026 |
May 05, 2026 |
Apr. 28, 2026 |
Mar. 25, 2026 |
Sep. 26, 2025 |
Jul. 28, 2025 |
Jul. 27, 2025 |
Jan. 30, 2025 |
Jul. 28, 2025 |
Jan. 30, 2025 |
Nov. 27, 2024 |
May 31, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Jan. 17, 2025 |
Jan. 15, 2025 |
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
900,000
|
|
900,000
|
148,148
|
|
|
|
| Ordinary shares, par value per share (in Dollars per share) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.135
|
|
$ 0.135
|
$ 0.135
|
|
|
|
| Reverse stock split conversion ratio |
1-for-10
|
|
|
|
|
|
|
|
|
|
1-for-15
|
|
1-for-9
|
|
|
|
|
|
|
|
|
| Reverse stock split conversion price |
$ 0.135
|
$ 0.0135
|
|
|
|
|
|
$ 0.0135
|
$ 0.0009
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
339,486
|
|
312,665
|
12,323
|
[1] |
|
|
| Ordinary shares, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
339,486
|
|
312,665
|
12,323
|
[1] |
|
|
| Number of ordinary shares issued in warrants exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
309,868,000
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ 864,000
|
$ 2,644,000
|
$ 0
|
|
|
|
| Ordinary Shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 202.5
|
| Number of ordinary shares issued in warrants exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,270
|
|
|
|
|
10,386
|
14,309
|
| Warrants exercisable for ordinary shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,270
|
|
|
|
|
10,386
|
14,309
|
| Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
|
|
|
|
|
|
|
|
|
$ 202.5
|
|
$ 202.5
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
|
|
|
|
|
|
|
$ 3,276,000
|
|
$ 3,276,000
|
|
|
|
|
|
|
|
|
|
| Placement agent fees and other offering expenses |
|
|
|
|
|
|
|
|
|
$ 462,000
|
|
$ 462,000
|
|
|
|
|
|
|
|
|
|
| Exercise price of placement agent warrants |
|
|
|
|
|
|
|
|
|
$ 276.6
|
|
$ 276.6
|
|
|
$ 253.1
|
|
|
|
|
|
|
| Placement agent cash fee in percentage |
|
|
|
|
|
|
|
|
|
8.00%
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
| Placement agent warrants issued as percentage of ordinary shares |
|
|
|
|
|
|
|
|
|
7.00%
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
| Sales Agent [Member] | At The Market Offering Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
6,408,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Expected sell amount on newly issued ordinary shares |
|
|
|
|
|
$ 76,000
|
$ 13,170,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse stock split conversion price |
$ 0.135
|
$ 0.0135
|
|
|
|
|
|
|
|
|
$ 0.0009
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse stock split conversion price |
|
|
|
|
|
|
|
|
|
|
$ 0.0135
|
|
$ 0.0009
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase in authorized share capital, shares |
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, shares authorized |
|
|
|
|
900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, total value of shares authorized |
|
|
|
|
$ 121,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value per share (in Dollars per share) |
|
|
|
$ 0.135
|
$ 0.135
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Sales Agent [Member] | At The Market Offering Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
176,811
|
|
|
|
|
|
|
|
| Expected sell amount on newly issued ordinary shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,085,000
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | 2024 Equity Incentive Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 Equity Incentive Plan, amendment description |
|
|
|
|
An
amendment to the Silexion Therapeutics Corp 2024 Equity Incentive Plan, effective as of January 1, 2026, to increase the number of ordinary
shares added annually on January 1st under the “evergreen” provision of the plan from (x) 5% of the Company’s issued
and outstanding ordinary shares, to (y) such number of ordinary shares as yields a pool of ordinary shares reserved under all equity incentive
plans of the Company that constitutes, in the aggregate, 10% of the issued and outstanding ordinary shares on a fully diluted basis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Reverse share split [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value per share (in Dollars per share) |
|
|
|
$ 0.0135
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reverse stock split conversion ratio |
|
|
|
1-for-10
|
1-for-10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of publicly held shares |
|
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities that can be called by placement agent warrants |
|
|
399,020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of placement agent warrants |
|
|
$ 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion price (in Dollars per share) |
|
|
$ 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt conversion amount |
|
|
$ 299,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt conversion number of shares issued |
|
|
59,853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Debt instrument conversion terms |
|
|
In
connection with the sale of 108,826 ordinary shares to investors under the ATM facility on May 2026 at an average price per share of $3.2,
the Company converted $105 of the principal amount under the Related Party Promissory Note into 32,648 ordinary shares, which it issued
to the Sponsor at the same price of $3.2 per share as in that transaction.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Foregoing conversions |
|
|
$ 1,229,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] | Warrants exercisable for ordinary shares [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued |
|
|
199,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
|
|
$ 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of ordinary shares issued in warrants exercised |
|
|
199,510
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants |
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent fees and other offering expenses |
|
|
$ 200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] | Warrants exercisable for ordinary shares [Member] | Tranche One [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued |
|
|
102,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
|
|
$ 40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Descriptions of warrant exercise condition |
|
|
(i)
102,250
were Series A warrants that had been issued in the Company’s public offering completed in September 2025 and had a five-year exercise
term and an exercise price of $40.0
per underlying ordinary share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] | Warrants exercisable for ordinary shares [Member] | Tranche Two [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued |
|
|
77,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
|
|
$ 40
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Descriptions of warrant exercise condition |
|
|
(ii)
77,875
were Series B Warrants that had been issued in that September 2025 public offering and had a one-year exercise term and an exercise
price of $40.0
per underlying ordinary share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] | Warrants exercisable for ordinary shares [Member] | Tranche Three [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued |
|
|
19,385
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued, price per share |
|
|
$ 113.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] | Placement Agent Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities that can be called by placement agent warrants |
|
|
13,966
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price of placement agent warrants |
|
|
$ 6.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent cash fee in percentage |
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Placement agent warrants issued as percentage of ordinary shares |
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] | Series C Warrants Exercisable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities that can be called by placement agent warrants |
|
|
204,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | May 2026 Inducement Offer [Member] | Series D Warrants Exercisable [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of securities that can be called by placement agent warrants |
|
|
194,520
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsequent Event [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, shares authorized |
|
|
|
|
5,900,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, total value of shares authorized |
|
|
|
|
$ 796,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ordinary shares, par value per share (in Dollars per share) |
|
|
|
|
$ 0.135
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|